2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide

C20H17F5N6O2 — CID 138680160

IUPAC2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide
SMILESO=C(CN1CCC(F)(F)CC1)Nc1ccnc(-c2cc(-c3noc(C(F)(F)F)n3)ccn2)c1
InChIInChI=1S/C20H17F5N6O2/c21-19(22)3-7-31(8-4-19)11-16(32)28-13-2-6-27-15(10-13)14-9-12(1-5-26-14)17-29-18(33-30-17)20(23,24)25/h1-2,5-6,9-10H,3-4,7-8,11H2,(H,27,28,32)
InChIKeyDUKJUWDUBFHZEC-UHFFFAOYSA-N
MW468.39 g/mol
LogP3.88
Rot. Bonds5

About 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide

2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide (PubChem CID 138680160) has the molecular formula C20H17F5N6O2 and a molecular weight of 468.39 g/mol. Its IUPAC name is 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide.

Molecular Properties

Compound Name2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide
PubChem CID138680160
Molecular FormulaC20H17F5N6O2
Molecular Weight468.39 g/mol
Exact Mass468.13
IUPAC Name2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide
SMILESO=C(CN1CCC(F)(F)CC1)Nc1ccnc(-c2cc(-c3noc(C(F)(F)F)n3)ccn2)c1
InChIInChI=1S/C20H17F5N6O2/c21-19(22)3-7-31(8-4-19)11-16(32)28-13-2-6-27-15(10-13)14-9-12(1-5-26-14)17-29-18(33-30-17)20(23,24)25/h1-2,5-6,9-10H,3-4,7-8,11H2,(H,27,28,32)
InChIKeyDUKJUWDUBFHZEC-UHFFFAOYSA-N
XLogP3.88
TPSA97.04 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500468.39
LogP ≤ 53.88
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide?
The IUPAC name of 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide (CID 138680160) is 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide.
What is the SMILES notation for 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide?
The canonical SMILES for 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide is O=C(CN1CCC(F)(F)CC1)Nc1ccnc(-c2cc(-c3noc(C(F)(F)F)n3)ccn2)c1.
What is the InChIKey of 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide?
The InChIKey is DUKJUWDUBFHZEC-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H17F5N6O2/c21-19(22)3-7-31(8-4-19)11-16(32)28-13-2-6-27-15(10-13)14-9-12(1-5-26-14)17-29-18(33-30-17)20(23,24)25/h1-2,5-6,9-10H,3-4,7-8,11H2,(H,27,28,32).
What are the key properties of 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide?
2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide has a molecular weight of 468.39 g/mol, XLogP of 3.88, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4,4-difluoropiperidin-1-yl)-N-[2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-pyridinyl]acetamide is sourced from PubChem (CID 138680160), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).